ABSTRACTS CLOSING 9 DECEMBER

Abstracts closing 9 December. Submit now so you don’t miss out!

EARLY BIRD CLOSING 7 FEBRUARY

Early Bird rates are available until 7 February. Register now and save!

Call for abstracts

Abstracts are closing for submission 9 December. Submit your abstract now for the NDLR 2020 Program.
For more information on the themes, guidelines and key deadlines, please click below. 

View invited speakers

We have a compelling line up of invited speakers for NDLR 2020.
Click the link to see who will be presenting.

Registration Now Open!

Register your attendance at NDLR 2020 Today.
Early Bird rates available until 7 February.

For more information click here

Home

The Scientific and Organising Committees invite you to participate in the 8th New Directions in Leukaemia Research (NDLR) meeting to be held at the Brisbane Convention and Exhibition Centre in Queensland, Australia, from Monday 23 March to Wednesday 25 March, 2020.

The goal of the NDLR conferences is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia to new therapies emerging in the clinic.

As one of the premier international leukaemia conferences, NDLR 2020 will again bring together early-career investigators and senior scientists. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, allowing new collaborations to be forged.

Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR conferences offer a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.

We look forward to seeing you at NDLR 2020.

Associate Professors Matthew McCormack & Ross Dickins (co-chairs)

NDLR 2018 Delegates